SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-23-245609
Filing Date
2023-09-28
Accepted
2023-09-28 16:05:26
Documents
5
Period of Report
2023-10-24

Document Format Files

Seq Description Document Type Size
1 DEF 14A d545310ddef14a.htm DEF 14A 247053
2 GRAPHIC g545310g12g12.jpg GRAPHIC 100747
3 GRAPHIC g545310g14g14.jpg GRAPHIC 95015
4 GRAPHIC g545310g40m34.jpg GRAPHIC 25465
5 GRAPHIC g545310g64q82.jpg GRAPHIC 36160
  Complete submission text file 0001193125-23-245609.txt   580710
Mailing Address 45 WIGGINS AVENUE BEDFORD MA 01730
Business Address 45 WIGGINS AVENUE BEDFORD MA 01730 781-430-8200
Stoke Therapeutics, Inc. (Filer) CIK: 0001623526 (see all company filings)

IRS No.: 471144582 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38938 | Film No.: 231289508
SIC: 2834 Pharmaceutical Preparations